Genetic Diversity of a Korean Echovirus 5 Isolate and Its Response to Antiviral Drugs
Author Information
Author(s): Park Kwisung, Song Jaehyoung, Baek Kyoungah, Lee Changgyun, Kim Donguk, Cho SamHyun, Park JoonSoo, Choi YoungJin, Kang Byunghak, Choi Hwajung, Cheon Doo-Sung
Primary Institution: Chungcheongnam-Do Institute of Health and Environmental Research
Hypothesis
What is the genetic diversity of the Korean echovirus 5 isolate and how does it respond to antiviral drugs?
Conclusion
The Korean echovirus 5 isolate shows genetic diversity and responds to amantadine and ribavirin, which exhibit antiviral activity.
Supporting Evidence
- The Korean echovirus 5 genome was sequenced and compared to a prototype strain.
- Amantadine and ribavirin were found to have antiviral activity against the Korean echovirus 5 isolate.
- No cytotoxicity was observed for the antiviral drugs at high concentrations.
- The study provides the first complete nucleotide sequence of the Korean echovirus 5 strain.
Takeaway
Scientists studied a virus called echovirus 5 from a sick boy in Korea and found that two medicines can help fight it.
Methodology
The study involved isolating the virus from a patient, sequencing its genome, and testing its response to five antiviral drugs.
Limitations
The study only tested five antiviral drugs and was based on a single isolate from one patient.
Participant Demographics
The isolate was taken from a young male patient with aseptic meningitis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website